Products containing hemp extracts high in CBD are gaining mainstream popularity, acceptance and federal legality. In this article, Lisa Pittman, nonresident fellow in drug policy, focuses on litigation issues particular to hemp.
According to the authors, as a leading agricultural state, Texas is poised to become the new leader in hemp production, whether for medicinal or industrial purposes.
According to the authors, developments in cannabis law, arbitration clause interpretation and the economic loss doctrine show that numerous facets of business litigation are changing rapidly.
Baker Institute director Edward P. Djerejian, former ambassador to Israel and to Syria, appeared on Al-Jazeera's "From Washington"
program to discuss the possible consequences of Jamal Khashoggi's disappearance (Arabic): https://youtu.be/J7-xALrG_3s.
Baker Institute director Edward P. Djerejian comments on a welcome moment of nonpartisanship after the April 21, 2018, funeral for former first lady Barbara Bush.
James A. Baker, III, and George P. Shultz — both former secretaries of state and Treasury secretaries — offer "A Conservative Answer to Climate Change" in a commentary for The Wall Street Journal.
James A. Baker, III, George P. ShulzFebruary 15, 2017
High cancer drug prices reduce access to therapy, cause treatment abandonment and financial bankruptcies, as well as severe emotional and family distress.